Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christie Ballantyne Added: 2 months ago
AHA Scientific Sessions 2025 - Dr Christie Ballantyne (Baylor College of Medicine, Houston, TX, US) discusses findings from the CORALreef HeFH trial, examining the efficacy and safety of enlicitide decanoate, an oral PCSK9 inhibitor, in adults with heterozygous familial hypercholesterolemia.This Phase 3, randomized, double-blind, placebo-controlled study evaluated 303 participants with… View more
Author(s): Frederick Raal Added: 2 years ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104). The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in… View more
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Testa is an Interventional Cardiologist working at the IRCCS Policinico San Donato in San Donato, Milan, Italy. He is Head of the Coronary Revascularization Unit as well as of the Clinical Research Unit. His areas of research range from platelet aggregation, intracoronary imaging and physiology related to structural heart disease, particularly the TAVI. He is also particularly… View more
Research Area(s) / Expertise: Job title: Adjunct Professor of Pharmacology
Research Area(s) / Expertise: Job title: Aggregate Professor of Internal Medicine